General Info
Rafael Damasio, as the Group CEO of Rafael Holdings, focuses on developing novel cancer and immune therapies through investments in clinical-stage oncology companies such as Cornerstone Pharmaceuticals and LipoMedix Pharmaceuticals. The investment thesis revolves around improving and extending the lives of patients with cancer through innovative therapeutics. Rafael Holdings is transitioning to a commercial enterprise from a clinical-stage company with ongoing Phase 3 trials. They are actively seeking a Chief Compliance and Ethics Officer with specific job requirements related to compliance and ethics in the pharmaceutical/biotech industry.
Location:
Country: Brazil
Industries:
Investment Regions: EU, NA
Investment Stages: pre-seed, seed
angel-individual
EU, NA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-found
AI Reasoning: Could not perform Google searches due to tool errors; no verifiable sources found to confirm any investment dates for Rafael Damasio. Given lack of external evidence, default to ‘not-found’. Unable to calculate date difference or confirm investments in Cornerstone Pharmaceuticals or LipoMedix from external sources.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Rafael Damasio
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI